(Reuters) - Dr. Reddy's Laboratories Ltd will pay $5 million to resolve U.S. claims that the Indian company sold prescription drugs in the United States in packaging that was not tested for child safety, according to court papers filed on Monday.
from Reuters: U.S. http://ift.tt/2kgelcK
//
0 comments:
Post a Comment